Literature DB >> 9106528

Mutation analysis of the HLA-H gene in Italian hemochromatosis patients.

M Carella1, L D'Ambrosio, A Totaro, A Grifa, M A Valentino, A Piperno, D Girelli, A Roetto, B Franco, P Gasparini, C Camaschella.   

Abstract

Hemochromatosis (HH) is an inborn error of iron metabolism, frequent among Caucasians, characterized by progressive iron loading that, if untreated, causes high morbidity and death. HLA-H, a putative HH gene, has recently been isolated. The large majority of patients so far studied are homozygous for a single mutation, which results in a cysteine-to-tyrosine substitution at amino acid 282 of the protein. A second, less frequent, variant, His63Asp, has an undefined role in the pathogenesis of the disease. Here we report that the Cys282Tyr change accounts for 69% of HH chromosomes in a series of 75 unrelated Italian patients who fulfilled well-defined criteria for HH diagnosis. Sixty-four percent of patients were Cys282Tyr homozygous, 10% were heterozygous, and 21% carried the normal allele. The same mutation was rare in normal controls. The His63Asp variant was less frequent but had a similar frequency among affected and normal chromosomes. Subjects without two copies of the Cys282Tyr change were both isolated patients and individuals from families with a 6p-linked disease. Mutation analysis of the HLA-H gene, carried out by RNA-SSCP in the latter patients, did not reveal any significant nucleotide abnormality in coding sequences and intron-exon boundaries. The absence of mutations in HLA-H gene was confirmed in three cases by direct sequencing. Major deletions or rearrangements of the gene were excluded by Southern blotting. The existence of patients with clinical and histological features of HH, but without mutations in HLA-H gene, suggests that in Italy the disease is more heterogeneous than reported in northern Europe.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106528      PMCID: PMC1712480     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP.

Authors:  G Sarkar; H S Yoon; S S Sommer
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

2.  Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.

Authors:  C Q Edwards; L M Griffen; D Goldgar; C Drummond; M H Skolnick; J P Kushner
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

3.  Development of RNA-SSCP protocols for the identification and screening of CFTR mutations: identification of two new mutations.

Authors:  L Bisceglia; A Grifa; L Zelante; P Gasparini
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

4.  Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations.

Authors:  Y M Deugnier; O Loréal; B Turlin; D Guyader; H Jouanolle; R Moirand; C Jacquelinet; P Brissot
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

5.  Is all genetic (hereditary) hemochromatosis HLA-associated.

Authors:  L W Powell; M L Bassett; E Axelsen; J Ferluga; J W Halliday
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

6.  Genetic history of phenylketonuria mutations in Italy.

Authors:  I Dianzani; S Giannattasio; L de Sanctis; E Marra; A Ponzone; C Camaschella; A Piazza
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

7.  Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors.

Authors:  C Velati; A Piperno; S Fargion; S Colombo; G Fiorelli
Journal:  Haematologica       Date:  1990 Jul-Aug       Impact factor: 9.941

8.  Isolation of CA dinucleotide repeats close to D6S105; linkage disequilibrium with haemochromatosis.

Authors:  C Stone; J J Pointon; E C Jazwinska; J W Halliday; L W Powell; K J Robson; A P Monaco; D J Weatherall
Journal:  Hum Mol Genet       Date:  1994-11       Impact factor: 6.150

9.  Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis.

Authors:  E C Jazwinska; W R Pyper; M J Burt; J L Francis; S Goldwurm; S I Webb; S C Lee; J W Halliday; L W Powell
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

10.  Linkage disequilibrium between cystic fibrosis and linked DNA polymorphisms in Italian families: a collaborative study.

Authors:  X Estivill; M Farrall; R Williamson; M Ferrari; M Seia; A M Giunta; G Novelli; L Potenza; B Dallapicolla; G Borgo
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

View more
  42 in total

1.  Of metals, mice, and men: what animal models can teach us about body iron loading.

Authors:  G J Anderson; L W Powell
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding.

Authors:  R E Fleming; W S Sly
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

4.  Sequence variation and haplotype structure at the human HFE locus.

Authors:  Christopher Toomajian; Martin Kreitman
Journal:  Genetics       Date:  2002-08       Impact factor: 4.562

5.  Rapid diagnostic test for detection of Cys282Tyr mutation in hereditary hemochromatosis.

Authors:  M T Andre; S Jacquemont; S Renault; F Airaud; O Herbert; J P Moisan; B Benichou; O Raguenes
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

6.  Hemochromatosis: clinical implications of genetic testing.

Authors:  P C Adams
Journal:  CMAJ       Date:  1998-07-28       Impact factor: 8.262

Review 7.  Targeted disruption of the HFE gene.

Authors:  E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

8.  Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum.

Authors:  A Waheed; S Parkkila; J Saarnio; R E Fleming; X Y Zhou; S Tomatsu; R S Britton; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  HFE polymorphisms affect survival of brain tumor patients.

Authors:  Sang Y Lee; Becky Slagle-Webb; Jonas M Sheehan; Junjia Zhu; Joshua E Muscat; Michael Glantz; James R Connor
Journal:  J Neurooncol       Date:  2014-12-10       Impact factor: 4.130

10.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.